Compare ImmunityBio Inc. Common Stock (IBRX) vs Trane Technologies plc (TT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Trane Technologies plc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.09 (market cap $10.39B), while Trane Technologies plc trades at $471.85 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 10.1× ImmunityBio Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IBRX | TT | |
|---|---|---|
Market Cap | $10.39B | $105.17B |
Volume | 11,509,049 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $11.55 | $503.46 |
52-Week Low | $1.98 | $376.43 |
Typical Hold Time | 6 Days | — |
Enterprise Value | $10.84B | $108.47B |
Dividend Yield | — | 0.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ImmunityBio (IBRX) trades at $9.80, down 3.16% on the day, amid a bullish technical setup and strong analyst support. The company reported revenue growth to $166 million in 2026 but remains deeply unprofitable with a net loss of $992 million. Recent FDA approval expansion for ANKTIVA in bladder cancer and high-profile executive appointments signal operational momentum, though cash burn remains a concern with negative operating cash flow.
Outlook is cautiously optimistic given the unanimous buy ratings and regulatory milestones, but investment carries high risk due to persistent losses, heavy reliance on financing, and competitive pressures. The stock's trajectory hinges on successful commercialization and pipeline execution to achieve profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Trane Technologies plc
Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →
